Influenza Vaccine Post Allogeneic Transplant

Summary

Study Design: This is a randomized, single center study to evaluate immune responses to the seasonal influenza vaccine in allogeneic hematopoietic stem cell transplant (HSCT) recipients who receive one vaccine or two vaccine doses one month apart. In addition, a cohort of healthy adult volunteers will be recruited as controls to confirm immune response to a single influenza vaccine.

Timeline

Start

2010-09

Primary completion

2011-06

Completion

2011-06

Drugs

Indications